Archive

Allianz: ECB talks up sustainable bond greenium

Climate-related policies and pronouncements from the European Central Bank (ECB) has generated a "persistent positive effect" on the 'greenium' for European sustainable bonds, according to research from Allianz.

Loan round-up: CreditAccess Grameen, social loan spotlight, FIBRA Macquarie ... and more

Fidelity: Biodiversity 'largest investment trend in our lifetime'

Investing in solutions to biodiversity loss will be a "megatrend", a portfolio manager at Fidelity International has said, while revealing 12 best-in-class firms.

Axa sets decarbonisation targets for P&C portfolios

Axa has announced new decarbonisation targets for both its insurance and investment portfolios, as well as publishing its 2023 climate and biodiversity report.

Vancity leaves NA100 launch investor group

Vancity Investment Management (VCIM) has stepped back from its role in the leading investor group of Nature Action 100 (NA100), as the biodiversity engagement initiative shifts towards its development phase.

Managing risk amid the 'third wave' of climate litigation

As climate litigation risk gathers momentum, Nadine Coudel and Robert Gardner look at what steps energy companies can take to identify and reduce these risks

Data providers neglecting impact, says KBIGI

Providers of sustainability data are failing to address the potential market for information on environmental and social impacts, according to KBI Global Investors (KBIGI).

Asian taxonomies 'better' at dealing with the transition, says ICMA

Taxonomies being developed across Asia are "better" at dealing with the transition to a net zero economy than are those in other jurisdictions such as the EU, an executive at the International Capital Market Association (ICMA) argued.

Columbia Threadneedle launches global social bond fund

Columbia Threadneedle Investments has launched a dedicated global social bond fund, nine years after it launched its ground-breaking UK social bond fund.

M&G invests $25m in traffic management company